Package Leaflet: Information for the User
Pramipexol Teva 0.088 mg tablets EFG
Pramipexol Teva 0.18 mg tablets EFG
Pramipexol Teva 0.35 mg tablets EFG
Pramipexol Teva 0.7 mg tablets EFG
pramipexol
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Pramipexol Teva contains the active substance pramipexole, which belongs to a group of medicines known as dopamine agonists. These medicines mimic the action of dopamine, a substance in the brain that is involved in controlling movement.
Pramipexol Teva is used to:
Do not take Pramipexol Teva
Warnings and precautions
Tell your doctor before you start taking Pramipexol Teva. Inform your doctor if you have or have had any of the following conditions or symptoms, especially:
Tell your doctor if you, your family or caregivers notice that you are developing impulses or cravings to behave in ways that are unusual for you and that you cannot resist the impulse, drive or temptation to perform certain activities that could harm yourself or others. This is called impulse control disorder and can include behaviours such as addiction to gambling, excessive eating or spending, abnormally high libido or preoccupation with sexual thoughts. Your doctor may need to adjust or stop your dose.
Tell your doctor if you, your family or caregivers notice that you are developing mania (excitement, agitation) or delirium (reduced consciousness, confusion or loss of contact with reality). Your doctor may need to adjust or interrupt your treatment.
Tell your doctor if you notice symptoms such as depression, apathy, anxiety, fatigue, sweating or pain when stopping or reducing treatment with Pramipexol Teva. If the problems persist for more than a few weeks, your doctor may need to adjust your treatment.
Tell your doctor if you notice an inability to keep the trunk and neck straight and upright (axial dystonia). In this case, your doctor may decide to adjust or modify your treatment.
Children and adolescents
Pramipexol Teva is not recommended for use in children or adolescents under 18 years of age.
Other medicines and Pramipexol Teva
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines, herbal remedies, health foods or supplements that you have obtained without a prescription.
You should avoid taking Pramipexol Teva with antipsychotic medicines.
Be cautious if you are taking the following medicines:
If you are taking levodopa, it is recommended to reduce the dose of levodopa when starting treatment with Pramipexol Teva.
Be cautious if you are taking sedative medicines (with a calming effect) or if you drink alcohol. In these cases, Pramipexol Teva may affect your ability to drive and use machines.
Taking Pramipexol Teva with food, drinks and alcohol
You should be cautious if you drink alcohol during treatment with Pramipexol Teva.
You can take Pramipexol Teva with or without food.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Your doctor will tell you if you should continue to take Pramipexol Teva.
The effect of Pramipexol Teva on the fetus is not known. Therefore, do not take Pramipexol Teva if you are pregnant unless your doctor tells you to.
Pramipexol Teva should not be used during breast-feeding. Pramipexol Teva may decrease milk production. Also, it may pass into breast milk and reach your baby. If the use of Pramipexol Teva is essential, breast-feeding should be discontinued.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Pramipexol Teva may cause hallucinations (seeing, hearing or feeling things that are not there). If this happens, do not drive or use machines.
Pramipexol Teva has been associated with somnolence and sudden sleep episodes, especially in patients with Parkinson's disease. If you experience these side effects, do not drive or use machines. Tell your doctor if this happens to you.
Pramipexol Teva contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per tablet, i.e. essentially “sodium-free”.
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor. Your doctor will tell you the correct dose.
You can take Pramipexol Teva with or without food. The tablets should be swallowed with water.
Parkinson's disease
The daily dose should be taken divided into 3 equal doses.
During the first week, the usual dose is 1 tablet of Pramipexol Teva 0.088 mg three times a day (equivalent to 0.264 mg per day):
1st week | |
Number of tablets | 1 tablet of Pramipexol Teva 0.088 mg three times a day |
Daily dose (mg) | 0.264 |
This dose will be increased every 5-7 days according to your doctor's instructions, until your symptoms are controlled (maintenance dose).
2nd week | 3rd week | |
Number of tablets | 1 tablet of Pramipexol Teva 0.18 mg three times a day or 2 tablets of Pramipexol Teva 0.088 mg three times a day | 1 tablet of Pramipexol Teva 0.35 mg three times a day or 2 tablets Pramipexol Teva 0.18 mg three times a day |
Daily dose (mg) | 0.54 | 1.1 |
The usual maintenance dose is 1.1 mg per day. However, it may be necessary to increase your dose further. If necessary, your doctor may increase your dose of tablets up to a maximum of 3.3 mg of pramipexole per day. It is also possible to reduce the maintenance dose to three tablets of Pramipexol Teva 0.088 mg per day.
Minimum maintenance dose | Maximum maintenance dose | |
Number of tablets | 1 tablet of Pramipexol Teva 0.088 mg three times a day | 1 tablet of Pramipexol Teva 0.7 mg and 1 tablet of Pramipexol Teva 0.35 mg three times a day |
Daily dose (mg) | 0.264 | 3.15 |
Patient with kidney disease
If you have moderate or severe kidney disease, your doctor will prescribe a lower dose. In this case, you should take the tablets only once or twice a day. If you have moderate kidney impairment, the usual starting dose is 1 tablet of Pramipexol Teva 0.088 mg twice a day. If you have severe kidney impairment, the usual starting dose is 1 tablet of Pramipexol Teva 0.088 mg per day.
Restless Legs Syndrome
The dose is usually taken once a day, in the evening, 2-3 hours before bedtime.
During the first week, the usual dose is 1 tablet of Pramipexol Teva 0.088 mg once a day (equivalent to 0.088 mg per day):
1st week | |
Number of tablets | 1 tablet of Pramipexol Teva 0.088 mg |
Daily dose (mg) | 0.088 |
This dose will be increased every 4-7 days according to your doctor's instructions, until your symptoms are controlled (maintenance dose).
2nd week | 3rd week | 4th week | |
Number of tablets | 1 tablet of Pramipexol Teva 0.18 mg or 2 tablets of Pramipexol Teva 0.088 mg | 1 tablet of Pramipexol Teva 0.35 mg or 2 tablets of Pramipexol Teva 0.18 mg or 4 tablets of Pramipexol Teva 0.088 mg | 1 tablet of Pramipexol Teva 0.35 mg and 1 tablet of Pramipexol Teva 0.18 mg or 3 tablets of Pramipexol Teva 0.18 mg or 6 tablets of Pramipexol Teva 0.088 mg |
Daily dose (mg) | 0.18 | 0.35 | 0.54 |
The daily dose for the treatment of Restless Legs Syndrome should not exceed 6 tablets of Pramipexol Teva 0.088 mg or a dose of 0.54 mg (0.75 mg of pramipexole salt).
If you stop taking your tablets for a few days and want to start treatment again, you should start again with the smallest dose and then gradually increase the dose as you did the first time. Ask your doctor if you have any doubts.
Your doctor will assess your treatment after 3 months to decide whether to continue or not with the treatment.
Patient with kidney disease
If you have severe kidney disease, Pramipexol Teva may not be a suitable treatment for your Restless Legs Syndrome.
If you take more Pramipexol Teva than you should
If you accidentally take too many tablets,
If you forget to take Pramipexol Teva
Do not worry. Simply omit that dose completely and take the next dose at the correct time.
Do not take a double dose to make up for forgotten doses.
If you stop taking Pramipexol Teva
Do not stop your treatment with Pramipexol Teva without consulting your doctor first. If you need to stop your treatment, your doctor will reduce your dose gradually. This reduces the risk of worsening symptoms.
If you have Parkinson's disease, you should not stop your treatment with Pramipexol Teva abruptly. Sudden stopping may cause a condition called neuroleptic malignant syndrome, which can be life-threatening. These symptoms include:
If you stop treatment or reduce the dose of Pramipexol Teva, you may also experience a medical condition called dopamine agonist withdrawal syndrome. The symptoms include depression, apathy, anxiety, fatigue, sweating or pain. If you experience these symptoms, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The classification of these adverse effects is based on the following frequencies:
Very Common | may affect more than 1 in 10 people |
Common | may affect up to 1 in 10 people |
Uncommon | may affect up to 1 in 100 people |
Rare | may affect up to 1 in 1,000 people |
Very Rare | may affect up to 1 in 10,000 people |
Frequency Not Known | cannot be estimated from the available data |
If you have Parkinson's disease, you may experience the following adverse effects:
Very Common:
Common:
Uncommon:
Rare:
Frequency Not Known:
Tell your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms
For the adverse effects marked with *, it is not possible to have a precise estimate of the frequency, as these adverse effects were not observed in clinical trials among 2,762 patients treated with pramipexol. The frequency category is probably no higher than "uncommon"
If you have Restless Legs Syndrome, you may experience the following adverse effects:
Very Common:
Common:
Uncommon:
Frequency Not Known:
Tell your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms
For the adverse effects marked with *, it is not possible to have a precise estimate of the frequency, as these adverse effects were not observed in clinical trials among 1,395 patients treated with pramipexol. The frequency category is probably no higher than "uncommon"
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine
Keep this medicine out of the sight and reach of children
Do not use this medicine after the expiration date that appears on the box, blister, or label of the bottle after EXP. The expiration date is the last day of the month indicated. Do not store above 25°C
Store in the original packaging to protect it from light and moisture
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment
Composition of Pramipexol Teva
The active ingredient is pramipexol
Each tablet contains 0.088 mg, 0.18 mg, 0.35 mg, 0.7 mg of pramipexol as 0.125 mg, 0.25 mg, 0.5 mg, or 1 mg of pramipexol dihydrochloride monohydrate, respectively
The other ingredients are mannitol, microcrystalline cellulose, sodium starch glycolate, povidone, magnesium stearate, sodium monostearate fumarate, colloidal silicon dioxide
Appearance of the Product and Package Contents
Marketing Authorization Holder
Teva B.V
Swensweg 5, 2031GA Haarlem
Netherlands
Manufacturer
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13
4042 Debrecen
Hungary
Pharmachemie B.V
Swensweg 5
Postbus 552
2003 RN Haarlem
Netherlands
Teva Czech Industries s.r.o
Ostravska 29, c.p. 305
747 70 Opava-Komarov
Czech Republic
Merckle GmbH
Ludwig-Merckle-Straße 3
89143 Blaubeuren
Germany
Balkanpharma Dupnitsa AD
3 Samokovsko Shosse Str
Dupnitsa 2600
Bulgaria
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG Tel: +32 38207373 | Lietuva UAB Teva Baltics Tel: +370 52660203 |
Luxembourg/Luxemburg ratiopharm GmbH Germany/Deutschland Tel: +49 73140202 | |
Ceská republika Teva Pharmaceuticals CR, s.r.o Tel: +420 251007111 | Magyarország Teva Gyógyszergyár Zrt Tel: +36 12886400 |
Danmark Teva Denmark A/S Tlf: +45 44985511 | Malta Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Deutschland TEVA GmbH Tel: +49 73140208 | Nederland Teva Nederland B.V Tel: +31 8000228400 |
Eesti UAB Teva Baltics Eesti filiaal Tel: +372 6610801 | Norge Teva Norway AS Tlf: +47 66775590 |
Ελλάδα Specifar Α.Β.Ε.Ε Τηλ: +30 2118805000 | Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070 |
España Teva Pharma, S.L.U Tel: +34 913873280 | Polska Teva Pharmaceuticals Polska Sp. z o.o Tel: +48 223459300 |
France Teva Santé Tél: +33 155917800 | Portugal Teva Pharma - Produtos Farmacêuticos, Lda Tel: +351 214767550 |
Hrvatska Pliva Hrvatska d.o.o Tel: +385 13720000 | România Teva Pharmaceuticals S.R.L Tel: +40 212306524 |
Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407117 | Slovenija Pliva Ljubljana d.o.o Tel: +386 15890390 |
Ísland Teva Pharma Iceland ehf Sími: +354 5503300 | Slovenská republika TEVA Pharmaceuticals Slovakia s.r.o Tel: +421 257267911 |
Italia Teva Italia S.r.l Tel: +39 028917981 | Suomi/Finland Teva Finland Oy Puh/Tel: +358 201805900 |
Κύπρος Specifar Α.Β.Ε.Ε Ελλάδα Τηλ: +30 2118805000 | Sverige Teva Sweden AB Tel: +46 42121100 |
Latvija UAB Teva Baltics filiale Latvija Tel: +371 67323666 | United Kingdom (Northern Ireland) Teva Pharmaceuticals Ireland Ireland Tel: +44 2075407117 |
Date of Last Revision of this Leaflet: {MM/AAAA}
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu